178 related articles for article (PubMed ID: 37036478)
1. Histogram analysis of quantitative parameters from synthetic MRI: correlations with prognostic factors in nasopharyngeal carcinoma.
Yang F; Li X; Li Y; Lei H; Du Q; Yu X; Li L; Zhao Y; Xie L; Lin M
Eur Radiol; 2023 Aug; 33(8):5344-5354. PubMed ID: 37036478
[TBL] [Abstract][Full Text] [Related]
2. Histogram analysis of synthetic magnetic resonance imaging: Correlations with histopathological factors in head and neck squamous cell carcinoma.
Yang F; Li Y; Lei H; Wei H; Du Q; Yu X; Li X; Zhao Y; Li L; Xie L; Lin M
Eur J Radiol; 2023 Mar; 160():110715. PubMed ID: 36753947
[TBL] [Abstract][Full Text] [Related]
3. Synthetic MRI quantitative parameters in discriminating stage T1 nasopharyngeal carcinoma and benign hyperplasia: Combination with morphological features.
Zhang H; Zhao J; Dai J; Chang J; Hu S; Wang P
Eur J Radiol; 2024 Jan; 170():111264. PubMed ID: 38103492
[TBL] [Abstract][Full Text] [Related]
4. Proposed modifications and incorporation of plasma Epstein-Barr virus DNA improve the TNM staging system for Epstein-Barr virus-related nasopharyngeal carcinoma.
Guo R; Tang LL; Mao YP; Du XJ; Chen L; Zhang ZC; Liu LZ; Tian L; Luo XT; Xie YB; Ren J; Sun Y; Ma J
Cancer; 2019 Jan; 125(1):79-89. PubMed ID: 30351466
[TBL] [Abstract][Full Text] [Related]
5. The utility of texture analysis based on quantitative synthetic magnetic resonance imaging in nasopharyngeal carcinoma: a preliminary study.
Yang F; Li Y; Li X; Yu X; Zhao Y; Li L; Xie L; Lin M
BMC Med Imaging; 2023 Jan; 23(1):15. PubMed ID: 36698156
[TBL] [Abstract][Full Text] [Related]
6. Investigation of the feasibility of synthetic MRI in the differential diagnosis of non-keratinising nasopharyngeal carcinoma and benign hyperplasia using different contoured methods for delineation of the region of interest.
Meng T; He H; Liu H; Lv X; Huang C; Zhong L; Liu K; Qian L; Ke L; Xie C
Clin Radiol; 2021 Mar; 76(3):238.e9-238.e15. PubMed ID: 33213835
[TBL] [Abstract][Full Text] [Related]
7. Histogram analysis of MR quantitative parameters: are they correlated with prognostic factors in prostate cancer?
Chen Y; Meng T; Cao W; Zhang W; Ling J; Wen Z; Qian L; Guo Y; Lin J; Wang H
Abdom Radiol (NY); 2024 Mar; ():. PubMed ID: 38546826
[TBL] [Abstract][Full Text] [Related]
8. Whole-Tumor Histogram and Texture Imaging Features on Magnetic Resonance Imaging Combined With Epstein-Barr Virus Status to Predict Disease Progression in Patients With Nasopharyngeal Carcinoma.
Li Q; Wang T; Huang Y; Li Q; Liu P; Grimm R; Fu C; Zhang Y; Gu Y
Front Oncol; 2021; 11():610804. PubMed ID: 33767984
[No Abstract] [Full Text] [Related]
9. Integrating Postradiotherapy MRI-Detected Lymph Node Necrosis and Pre- and Posttreatment Epstein-Barr Virus-DNA for Risk Stratification in Nasopharyngeal Carcinoma.
Cao D; Li S; Li H; Liu L; Wang X; Quan T
J Magn Reson Imaging; 2023 Jul; 58(1):108-119. PubMed ID: 36326089
[TBL] [Abstract][Full Text] [Related]
10. Value of dynamic contrast-enhanced magnetic resonance imaging for determining the plasma Epstein-Barr virus status and staging of nasopharyngeal carcinoma.
Sriyook A; Lertbutsayanukul C; Jittapiromsak N
Clin Imaging; 2021 Apr; 72():1-7. PubMed ID: 33190027
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of serum Epstein-Barr virus antibodies in patients with nasopharyngeal carcinoma and undetectable pretreatment Epstein-Barr virus DNA.
Yao JJ; Lin L; Jin YN; Wang SY; Zhang WJ; Zhang F; Zhou GQ; Cheng ZB; Qi ZY; Sun Y
Cancer Sci; 2017 Aug; 108(8):1640-1647. PubMed ID: 28603915
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Value of Serum Epstein-Barr Virus Antibodies and Their Correlation with TNM Classification in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma.
Zhang WR; Du YY; Guo CY; Zhou HX; Lin JY; Meng XH; Mo HY; Luo DH
Cancer Res Treat; 2021 Oct; 53(4):991-1003. PubMed ID: 33494127
[TBL] [Abstract][Full Text] [Related]
13. A Randomized Controlled Trial on Evaluation of Plasma Epstein-Barr Virus Biomarker for Early Diagnosis in Patients With Nasopharyngeal Carcinoma.
Liu W; Li H; Sheng H; Liu X; Chi P; Wang X; Mao M
Adv Ther; 2020 Oct; 37(10):4280-4290. PubMed ID: 32780356
[TBL] [Abstract][Full Text] [Related]
14. Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma.
Shao JY; Li YH; Gao HY; Wu QL; Cui NJ; Zhang L; Cheng G; Hu LF; Ernberg I; Zeng YX
Cancer; 2004 Mar; 100(6):1162-70. PubMed ID: 15022282
[TBL] [Abstract][Full Text] [Related]
15. Histogram analysis of diffusion kurtosis imaging of nasopharyngeal carcinoma: Correlation between quantitative parameters and clinical stage.
Xu XQ; Ma G; Wang YJ; Hu H; Su GY; Shi HB; Wu FY
Oncotarget; 2017 Jul; 8(29):47230-47238. PubMed ID: 28525383
[TBL] [Abstract][Full Text] [Related]
16. Prognostic values of the integrated model incorporating the volume of metastatic regional cervical lymph node and pretreatment serum Epstein-Barr virus DNA copy number in predicting distant metastasis in patients with N1 nasopharyngeal carcinoma.
Yao JJ; Zhou GQ; Wang YQ; Wang SY; Zhang WJ; Jin YN; Zhang F; Li L; Liu LZ; Cheng ZB; Ma J; Qi ZY; Sun Y
Chin J Cancer; 2017 Dec; 36(1):98. PubMed ID: 29284539
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of systemic inflammation response index in nasopharyngeal carcinoma with negative Epstein-Barr virus DNA.
Yuan X; Yang H; Zeng F; Zhou S; Wu S; Yuan Y; Cui L; Feng H; Lin D; Chen Z; Liu X; Chen J; Wang F
BMC Cancer; 2022 Aug; 22(1):858. PubMed ID: 35932022
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Epstein-Barr Virus Serological Tools for the Screening and Risk Assessment of Nasopharyngeal Carcinoma: a Large Population-based Study.
Guo J; Cui Z; Zheng Y; Li X; Chen Y
Pathol Oncol Res; 2020 Oct; 26(4):2185-2190. PubMed ID: 32222897
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of EBV DNA and platelet-to-lymphocyte ratio in patients with non-metastatic nasopharyngeal carcinoma: a retrospective study.
Dong H; Huang Z; Yang D; Li Z; Huang H; Meng Z; Qin Y; Kang M
BMC Cancer; 2023 Jul; 23(1):673. PubMed ID: 37464319
[TBL] [Abstract][Full Text] [Related]
20. Synthetic MRI and diffusion-weighted imaging for differentiating nasopharyngeal lymphoma from nasopharyngeal carcinoma: combination with morphological features.
Zhang H; Hu L; Qin F; Chang J; Zhong Y; Dou W; Hu S; Wang P
Br J Radiol; 2024 May; ():. PubMed ID: 38733577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
